General MedicationsORALGeneric
VERMOX
MEBENDAZOLE
Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview VERMOX is listed in Drugs@FDA under application 208398 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient MEBENDAZOLE Form and strength TABLET, CHEWABLE;ORAL - 500MG Sponsor JANSSEN PHARMS Submission history Latest submission status date: 2021-09-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview VERMOX is listed in Drugs@FDA under application 208398 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MEBENDAZOLE Form and strength TABLET, CHEWABLE;ORAL - 500MG Sponsor JANSSEN PHARMS Submission history Latest submission status date: 2021-09-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.